The salivary glands have a fascination for the physiologist because of th2ir favourable position for observation of a gland which is under autonomic control and which is readily accessible to cannulation. Despite this, there is still uncertainty about thcir innervation. There is a parasympathetic and a sympathetic nerve supply but the exact role of each is debatable and indeed there may be species differences. Spontaneous secretion is prominent in the parotid gland of the sheep and the sublingual gland of the cat and is probably present in human beings though small in amount ard perhaps inter- 
Sympathetic efferent
diagram and the principal taste pathways on the left. The pathways for appreciation of taste and for the salivary reflex are uncertain after the nucleus ofthe tractus solitarius.
middle ear, and so to the lesser superficial petrosal nerve which leaves the skull by the foramen ovale to the otic ganglion. Post-ganglionic fibres enter the auriculo-temporal nerve which supplies the parotid gland. The auriculo-temporal nerve also carries the sympathetic supply which reaches it from the superior cervical ganglion by a plexus around the external carotid artery and its branches. The preganglionic fibres emerge from the first and second thoracic segments of the spinal cord and ascend the cervical sympathetic chain to relay in the superior cervical ganglion. Stimulation of the glossopharyngeal nerve, a cholinergic nerve, causes secretion of salivary juice from the parotid gland which is accompanied by vasodilatation. Stimulation of the sympathetic adds to the secretion in some animals though in man the parotid may not take part in this response (Folkow and Laage-Hellman, 1960) . It is not yet certain whether this is a true secretagogic effect or due to vascular changes in the gland. Blood vessels in the parotid constrict for a short time then there is a long phase of dilatation. The myoepithelial basket cells contract on sympathetic stimulation, expressing saliva from the acini, and the sympathetic control may be responsible for contraction of the salivary ducts.
One of the most difficult questions is the relation between the salivary secretion and the blood flow. The present paper does not lead to a definitive conclusion but may contribute to a more recent concept, namely that vasodilatation in the gland is secondary to the salivary secretion. It has been recognized for a century that reflex stimulation of salivation is accompanied by vasodilatation in the glands but these always occur together. Many have considered that the increased vascularity is responsible for the flow of saliva. Ungar and Parrot (1936) started a new approach when they suggested that the vasodilator activity of saliva shown by earlier workers might be due to a local hormone then called kallikrein. Hilton and Lewis (1956) concluded from a series of experiments designed to elucidate the relation between cholinergic nerve supply and vasodilatation that the latter is due to an intracellular enzyme which escapes from the gland cells during activity to act upon a protein in the interstitial fluid, forming a vasodilator polypeptide which they consider to be bradykinin (also named kallidin by other workers). The intracellular enzyme is considered to be kallikrein. This theory would account for the postconstriction vasodilatation following sympathetic stimulation as well as for the parasympathetic effect.
One difficulty is that the secretory response to parasympathetic stimulation can be blocked with atropine without affecting the vasodilatation. So far as the sympathetic is concerned, there is some evidence in the cat for the presence of sympathetic vasodilator fibres whose secretion is not blocked by atropine (Emmelin, 1955) .
The case presented here is worth describing as a rare syndrome not well recognized, but it has also provided an opportunity to test the bradykinin hypothesis in a human being.
CASE REPORT
An unmarried woman then aged 24 attended the Neurological Unit in 1954 complaining that for three months she had suffered from headache and difficulty with vision because she could not change focus rapidly. She had noticed that the left pupil was enlarged during this period. Six months later the right pupil suddenly enlarged and vision of that eye became blurred. Examination showed myotonic pupils and myotonia of lens accommodation associated with absence of knee and ankle jerks (HolmesAdie syndrome). It was found that procaine block of the stellate ganglion relieved her symptoms. Pilocarpine drops and lenses to assist reading did not relieve symptoms and she was unable to continue with her clerical work. In view of the response to sympathetic block, bilateral stellate ganglionectomy was carried out by Mr BLOCK OF OTIC GANGLION Lignocaine 2 %, with adrenaline I in 80,000 (Xylocaine), was injected (8 ml.) into the neighbourhood of the left otic ganglion with the intention of obtaining complete parasympathetic block of the left parotid while any post-ganglionic sympathetic fibres still remaining would also be blocked, though it seemed unlikely that there could be any. The effect was unequivocal. The patient could now suck acid drops or lemon juice without any pain. This was not due to spread of lignocaine to the mandibular nerve as there was no loss of sensation in the skin of the face or mucosa of the mouth. There was slight tingling of both lips on the left.
The left pupil increased in diameter but both still reacted myotonically to light.
TESTS FOR HYPERSENSITIVITY OF END-ORGANS It was considered that the unilateral dilatation of the pupil in the last experiment could be due to hypersensitivity to adrenaline in the local anaesthetic. Adrenaline hydrochloride, 1 in 1,000, was injected intramuscularly in a dose of 0-125 ml.,calculated to be the equivalent of that administered with the lignocaine injection. During the period three to 10 minutes after the injection the left pupil was a little larger than the right, confirming that there was end-organ hypersensitivity. It was noted in both experiments that no parotid pain was produced. Unfortunately the secretion of saliva was not noted, but it may be concluded that even if the secretory cells were hypersensitive to adrenaline this did not provoke pain.
Edrophonium chloride (Tensilon), a short-acting drug with anti-cholinesterase and parasympathomimetic properties, was injected intravenously (10 mg. 3 Hexamethonium reduced both secretion and pain, and both were stopped by blocking the salivary reflex at the otic ganglion. This incidentally also shows that pain was confined to the parotid gland and did not involve the submandibular and sublingual glands which receive their parasympathetic supply from the facial nerve via the chorda tympani.
4 There was no evidence of hypersensitivity of cholinergic or adrenergic receptors on secretory cells in the parotid gland.
THE MECHANISM OF VASODILATATION
These experiments showed that pain was related to parasympathetic activity but that it was unlikely to be due to hypersecretion of saliva. The alternative explanation that it was caused by reflex congestion of the gland seems likely since the appearance of pain was associated in time with unilateral nasal congestion and flushing of the face. It is well accepted that stimulation of the parasympathetic nerve to a salivary gland causes vasodilatation as well as secretion, and that sympathetic stimulation causes vasoconstriction which is at least sometimes followed by vasodilatation. There has been a great deal of discussion regarding the mechanism of vasodilatation since it was demonstrated by Claude Bernard (1858) . This was for many years considered to prove the existence of vasodilator nerves in, at least, the chorda tympani of the dog. Carlson (1907) showed that stimulation of the sympathetic trunk in the neck of the cat usually caused marked vasodilatation in the submaxillary gland. Emmelin (1955) showed that sympathetic vasoconstriction could be dissociated from secretion but that sympathetic vasodilatation could not. The apparently contradictory reports of early investigators are well reviewed by Burgen and Emmelin (1961) .
The concept of active vasodilatation by parasympathetic vasomotor nerves has never been completely accepted. Heidenhain (1872) reported that vasodilatation could still be elicited after suppression of secretion by atropine but Henderson and Loewi (1905) found that vasodilatation was reduced and suggested that it was secondary to some metabolite released by the active gland. Barcroft (1914) showed that submaxillary gland metabolism increased on stimulation of the chorda tympani even when the secretory response was blocked by atropine. In the following years the vasodilator effect of saliva was discovered and at first attributed to acetylcholine in the juice. Ungar and Parrot (1936) re-examined the problem and concluded that it was due to the presence of a local hormone, 'kallikrein'. Hilton and Lewis (1956) found that vasodilatation in the submaxillary gland of the cat was related to activity of cholinergic nerve fibres but that the agent responsible was not acetylcholine. In an important series of investigations they found that the perfusate of an active salivary gland contained a substance which caused vasodilatation (and contraction of smooth muscle) only after it had been incubated with plasma. They concluded that activity in secretor cells causes the escape of an intracellular enzyme into the interstitial fluid where it reacts with protein to form the vasodilator polypeptide bradykinin (also known as kallidin) which is removed by the lymphatics. The intracellular enzyme is identified with the kallikrein of Ungar and Parrot (1936) .
The bradykinin theory would explain the vasodilatation accompanying secretion whether parasympathetic or sympathetic in origin. Nevertheless, Burgen and Emmelin (1961) feel that it is not possible to reject the concept of nerve fibres capable of producing vasodilatation without preceding salivary secretion, even if they act via kallikrein. Terroux, Sekelj, and Burgen (1959) showed that the oxygen consumption of the dog's submaxillary gland was directly related to the rate of saliva flow but the blood flow was not. Salivary flow and gland metabolic rate were depressed by atropine without affecting the vasodilator response (which in fact tended to increase with stimulation because of the lack of haemoconcentration when no fluid was withdrawn by salivary secretory cells). It does not necessarily follow that the liberation of an intracellular enzyme when a gland is stimulated is directly correlated with the cellular oxygen consumption, but it is obvious that the bradykinin theory is not yet accepted by all authorities. We have taken the opportunity to investigate the role of bradykinin within the limits possible in a cooperative patient, assuming that pain in the parotid gland was an indication of vasodilatation within the gland.
STUDIES ON BRADYKININ
On 26 June 1961 both parotid ducts were cannulated with fine polythene tubing. Secretion was stimulated by placing lemon juice on the patient's tongue. This caused profuse salivation accompanied by severe parotid pain. Twentyfive ml. of watery saliva was obtained from the left (painful) gland and 10 ml. from the other. These were submitted to Dr. W. E. Brocklehurst for estimation of their content of bradykinin. Unfortunately the tube containing saliva from the painless right parotid was broken in the centrifuge. The saliva from the painful left parotid gland contained a substance which caused contraction of guinea-pig ileum equivalent to that caused by 8 ,uzg./ml. bradykinin. The very small amount made it impracticable to characterize the substance further by testing the chymotrypsin response. The normal range for the human subject is unknown but the assay is certainly very small and does not suggest excess.
The second approach was to attempt to block the action of bradykinin on the blood vessels. It is known that salicylates and antihistamine drugs have some such effect (Collier and Shorley, 1960) .
ACETYLSALICYLIC ACID Acetylsalicylic acid soluble, (B.P.), four tablets given before meals, did not prevent reflex pain. PROMETHAZINE Promethazine, as reported above, produced no more effect than could be attributed to its anticholinergic effect. The possibility of histaminergic vasodilator nerves also seems to be excluded.
HOMOCHLORCYCLIZINE Homochlorcyclizine (SA-97 Abbott) antagonizes acetylcholine, histamine, 5-hydroxytryptamine, and the slow-reacting substance (SRS-A) of Brocklehurst (Kimura, Young, and Richards, 1960) . Its activity with bradykinin is unknown but its wide spectrum of activity on tissue hormones suggested a trial. Unlabelled tablets and dummy tablets of identical appearance were obtained for trial. The active tablets contained 25 mg. of the drug. Two tablets were given thrice daily 30 minutes before meals, three days on one tablet then three days on the other. The authors did not know which tablet contained the active drug until the trial ended. The patient was asked to record her experience with meals and to try the effect of sucking an acid drop each day. She obtained no useful relief from either tablet and indeed the control tablet gave the better response.
It was concluded from these experiments that there was no evidence of excess secretion of bradykinin in saliva from the affected gland (though this requires confirmation), and that drugs believed to antagonize bradykinin did not relieve the pain experienced with reflexly stimulated salivation. On the contrary, the relief obtained was less than that from anticholinergic drugs, especially Monodral. As the latter did not relieve pain ccmpletely, despite unpleasant dryness of the mouth and visual blurring, the decision was taken to destroy the gland secretion by a small dose of radiotherapy. This reduced the severity of pain for about nine months but at the time of writing there has been some recurrence. This may suggest that vasodilatation is independent of secretory activity, and our other findings suggest that they are related only by common reflex stimulation. We find no evidence of increased bradykinin formation and there is at present no reason to believe that post-ganglionic sympathectomy renders the parotid gland vessels hypersensitive to the polypeptide. Our findings would be quite compatible with the presence of vasodilator nerves. As Barcroft (1914) has written before about this problem: 'It is not possible on the evidence at hand either to prove or to disprove it'.
DISCUSSION
The myotonic contraction, well known in the pupil in patients with the Holmes-Adie syndrome, also involves the ciliary muscle causing slowness in accommodation. The inability to change focus rapidly when looking up from a book is a great inconvenience to a clerical worker. The time for relaxation of accommodation on looking from a near to a distant object can be accelerated by blocking the cervical sympathetic nerves with local anaesthetic. The rate of relaxation is not altered, but the range of change required is smaller (Russell, 1956 Gardner and Abdullah (1955) of parotid pain on eating in 14 patients who had superior cervical ganglionectomy. Patients who also had a preganglionic sympathectomy on the other side had no pain on that side. Pain usually started in the second week after operation. In most of their patients it lasted for only a few seconds at the beginning of a meal, and tended to become milder in a few months though it did not disappear. They also found that atropine did not abolish the pain while depressing secretory response but that both were depressed by tetraethylammonium chloride, which acts in the same way as the hexamethonium used by us. They conclude that absence of the tonic vasoconstrictor effect of the sympathetic nerve allows excess 'parasympathetic' vasodilatation but that there is sufficient autonomous activity in the de-afferented ganglion (pre-ganglionic section) to keep parasympathetic vasodilatation within physiological bounds. Their approach to therapy was more heroic than ours. On the assumption that the autonomic balance would thereby be restored, they sectioned the glossopharyngeal nerve (IX) intracranially. In one of their cases this operation did not have the desired effect. They make the interesting suggestion that some parasympathetic fibres reach the parotid gland from the facial nerve. Reichert and Poth (1933) reached the same conclusion when they observed that section of either the glossopharyngeal nerve (intracranially) or the chorda tympani (in the middle ear) in three patients decreased the secretion from all three salivary glands. We have nothing to contribute on this aspect since the response to otic ganglion/auriculotemporal block in our case was so complete.
This unusual syndrome has points in common with the auriculo-temporal syndrome of Frey (1923) , facial hyperaemia and sweating after destruction ofthe auriculo-temporal nerve, and the similar unilateral submental hyperaemia and sweating after damage to the chorda tympani (Uprus, Gaylor, and Carmichael, 1934) . Unilateral sweating of the face followed superior cervical ganglionectomy in a patient in whom an extracranial portion of the ipsilateral glossopharyngeal nerve had been resected and the sensory root of the trigeminal nerve sectioned. The sweating response was evoked with a salivary reflex but there was no obvious flushing of the face (Wilson, 1936) . Uprus et al. (1934) found that atropine abolished submental sweating but flushing still occurred on eating an apple. They conclude that atropine blocks the secretory activity of the chorda tympani without impairing its vasodilator activity. Blocking the chorda tympani temporarily blocked the whole of the response on eating but cervical sympathetic block did not. Writers on these syndromes do not stress the vascular response and assume the presence of vasodilator nerves. It would be interesting to know if the vascular response occurs in the absence of the denervated salivary gland. A recent review of the auriculo-temporal syndrome by Glaister, Hearnshaw, Heffron, Peck, and Patey (1958) is introduced by the comment that 'gustatory sweating . . . may be associated with flushing of the skin in the same region' but it was minimal or absent in their cases which were all the result of excision of the parotid gland. They dismiss Frey's theory that gustatory sweating is due to a diffusion of a choline-like substance from the parotid gland 'since the syndrome (sic) may occur after total parotidectomy'. By the same token if their observation that flushing is absent from the syndrome in these cases is confirmed, it might be suggested that flushing is not caused by vasodilator nerves but by diffusion from the gland of a substance which may be bradykinin. Kidd (1955) specifically mentions ipsilateral flushing of the face after total parotidectomy and this occurred in the skin supplied by the auriculo-temporal nerve. If the nerve was sectioned the Frey syndrome was rare and was possibly associated with incomplete neurectomy. The possibility of diffusion from a salivary gland can be excluded in the case of the pain in the lower limbs which may follow lumbar sympathectomy. Tracy and Cockett (1957) noted a characteristic latency of 10 to 17 days between operation and onset of pain, and pointed out that there was excessive sweating in the painful dermatomes. Unfortunately they did not consider the possibility of end-organ hypersensitivity and do not discuss skin temperature or pilomotor changes. Nevertheless, it appears that post-sympathectomy vasodilatation and/or pain are not confined to salivary glands. Though we are not prepared to reject the possibility of a hormonal vasodilator, our study supports the older concept of a parasympathetic vasodilator nerve supply to the parotid gland. 
